RSRM reduces price of rights shares

Ratanpur Steel Re-Rolling Mills (RSRM) has decided to reduce the issue price of their proposed rights shares to Tk 15 each (including premium of Tk 5) instead of Tk 20, which was recommended earlier, subject to the approval of shareholders.

It is going to issue two rights shares against every three shares.

Indo-Bangla Pharma to raise production capacity

Indo-Bangla Pharmaceuticals has entered into a manufacturing agreement with RHK Global (HK), Hong Kong under which Super Tramex-100mg tablets will be produced in the former’s plant.

Every year 120 crore tablets will be produced, which is projected to generate Tk 60 crore in revenues.